CNPR Drug Development Process 4 — Questions and Answers
Question 1: Which preclinical requirement must be completed before an IND application can be filed with the FDA?
- Phase I safety data in humans
- Adequate toxicology and pharmacology studies in animals (Correct answer)
- A completed Phase III efficacy trial
- An approved manufacturing facility inspection
Correct answer: Adequate toxicology and pharmacology studies in animals
Before filing an IND, sponsors must complete animal toxicology and pharmacology studies sufficient to predict safety for initial human exposure.
Question 2: A drug's 'therapeutic index' (TI) measures the relationship between:
- Efficacy at the target receptor and patient compliance rates
- The toxic dose and the effective dose — a narrow TI indicates a higher risk drug (Correct answer)
- The drug's half-life and its dosing interval
- The drug's bioavailability and its protein binding percentage
Correct answer: The toxic dose and the effective dose — a narrow TI indicates a higher risk drug
The therapeutic index (TD50/ED50) compares the dose causing toxicity to the dose producing the desired effect; a narrow TI means little margin between effective and harmful doses.
Question 3: What does 'off-label' drug use mean?
- Using an expired drug after its shelf-life date
- Prescribing a drug for a use, population, or dose not listed in FDA-approved labeling (Correct answer)
- Selling a drug without FDA approval
- Using a generic drug in place of its brand-name equivalent
Correct answer: Prescribing a drug for a use, population, or dose not listed in FDA-approved labeling
Off-label use is legally permissible for physicians but pharmaceutical reps cannot promote drugs for unapproved indications.
Question 4: Which organization accredits pharmaceutical sales training programs and awards the CNPR certification?
- The Pharmaceutical Research and Manufacturers of America (PhRMA)
- The National Association of Pharmaceutical Sales Representatives (NAPSRx) (Correct answer)
- The American Pharmacists Association (APhA)
- The FDA Center for Drug Evaluation and Research (CDER)
Correct answer: The National Association of Pharmaceutical Sales Representatives (NAPSRx)
NAPSRx (National Association of Pharmaceutical Sales Representatives) administers and awards the CNPR certification for pharmaceutical sales professionals.
Question 5: In the context of clinical trials, 'informed consent' requires that:
- A physician must enroll all patients without disclosing risks to avoid bias
- Participants voluntarily agree to a study after receiving complete information about risks and benefits (Correct answer)
- The sponsor can withhold certain information to prevent nocebo effects
- Only patients with previous trial experience need to sign consent forms
Correct answer: Participants voluntarily agree to a study after receiving complete information about risks and benefits
Informed consent is an ethical and legal requirement ensuring participants understand the study's purpose, risks, and their right to withdraw before agreeing to participate.
Question 6: What is a 'surrogate endpoint' in clinical research?
- A backup patient recruited when a primary patient withdraws
- A measurable biological marker used as a substitute for a clinical outcome (Correct answer)
- A secondary statistician who validates the primary analysis
- A placebo given when the active drug is temporarily unavailable
Correct answer: A measurable biological marker used as a substitute for a clinical outcome
Surrogate endpoints (like cholesterol levels or tumor size) are biomarkers reasonably likely to predict clinical benefit, allowing faster trial completion than waiting for actual disease outcomes.
Question 7: The FDA's MedWatch program is designed to:
- Monitor pharmaceutical sales force compliance with promotional regulations
- Collect voluntary safety reports on adverse events and product problems from healthcare professionals and patients (Correct answer)
- Manage the schedule of controlled substance prescriptions nationwide
- Track drug shortages and coordinate emergency supply chains
Correct answer: Collect voluntary safety reports on adverse events and product problems from healthcare professionals and patients
MedWatch is the FDA's safety information and adverse event reporting system, allowing healthcare professionals and patients to report safety concerns post-approval.
CNPR Drug Development Process 4
Which preclinical requirement must be completed before an IND application can be filed with the FDA?